Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,641 | 358 | 99.8% |
| Education | $12.02 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $915.34 | 53 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $734.53 | 50 | $0 (2022) |
| GlaxoSmithKline, LLC. | $621.93 | 46 | $0 (2024) |
| Novo Nordisk Inc | $444.15 | 34 | $0 (2024) |
| Lilly USA, LLC | $432.92 | 30 | $0 (2024) |
| PFIZER INC. | $419.54 | 29 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $356.87 | 19 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $349.45 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $270.67 | 20 | $0 (2024) |
| Amgen Inc. | $195.49 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $239.77 | 12 | Novo Nordisk Inc ($36.48) |
| 2023 | $455.39 | 24 | AstraZeneca Pharmaceuticals LP ($166.44) |
| 2022 | $555.40 | 30 | AstraZeneca Pharmaceuticals LP ($198.27) |
| 2021 | $471.10 | 26 | GlaxoSmithKline, LLC. ($91.22) |
| 2020 | $453.29 | 27 | AstraZeneca Pharmaceuticals LP ($109.00) |
| 2019 | $804.66 | 52 | Janssen Pharmaceuticals, Inc ($187.58) |
| 2018 | $1,186 | 72 | Amgen Inc. ($151.19) |
| 2017 | $1,487 | 117 | Janssen Pharmaceuticals, Inc ($262.93) |
All Payment Transactions
360 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Oncology | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: RESPIRATORY | ||||||
| 08/19/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: VACCINE | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $25.27 | General |
| 06/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: DIABETES | ||||||
| 05/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Diabetes | ||||||
| 05/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.27 | General |
| Category: PSYCHIATRY | ||||||
| 04/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Diabetes Care | ||||||
| 04/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: DIABETES | ||||||
| 02/29/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Oncology | ||||||
| 12/01/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Diabetes | ||||||
| 11/27/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $28.42 | General |
| 11/20/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.65 | General |
| Category: PSYCHIATRY | ||||||
| 11/17/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: RESPIRATORY | ||||||
| 10/26/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $31.51 | General |
| 10/05/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Diabetes | ||||||
| 09/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: DIABETES | ||||||
| 08/28/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Oncology | ||||||
| 07/28/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.86 | General |
| 06/30/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.83 | General |
| 06/13/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Oncology | ||||||
| 06/09/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,678 | 4,252 | $601,751 | $319,318 |
| 2022 | 26 | 3,372 | 5,286 | $650,935 | $331,388 |
| 2021 | 25 | 3,183 | 4,883 | $556,666 | $277,638 |
| 2020 | 32 | 3,788 | 5,970 | $605,932 | $265,312 |
All Medicare Procedures & Services
116 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 457 | 1,390 | $278,000 | $126,732 | 45.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 229 | 246 | $61,500 | $27,862 | 45.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 201 | 201 | $30,150 | $26,988 | 89.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 237 | 240 | $24,000 | $17,356 | 72.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 103 | 112 | $22,400 | $16,143 | 72.1% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 53 | 105 | $18,375 | $12,651 | 68.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 39 | 45 | $19,125 | $10,028 | 52.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 50 | 107 | $13,375 | $8,439 | 63.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 127 | $15,875 | $8,351 | 52.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 55 | 134 | $13,400 | $7,379 | 55.1% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Office | 2023 | 71 | 74 | $9,250 | $7,121 | 77.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 89 | 107 | $8,560 | $6,633 | 77.5% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 76 | 206 | $12,360 | $5,455 | 44.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 25 | 25 | $5,000 | $4,303 | 86.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $11,000 | $4,173 | 37.9% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 25 | 25 | $4,375 | $3,162 | 72.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 291 | 305 | $15,250 | $3,073 | 20.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 54 | 72 | $3,600 | $2,797 | 77.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 59 | 61 | $4,880 | $2,587 | 53.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 44 | 54 | $3,780 | $2,363 | 62.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 69 | 69 | $2,970 | $2,335 | 78.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 19 | 22 | $2,750 | $2,206 | 80.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $2,200 | $1,897 | 86.2% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 16 | 186 | $4,650 | $1,699 | 36.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $3,025 | $1,643 | 54.3% |
About Dr. James Gittzus, MD
Dr. James Gittzus, MD is a Internal Medicine healthcare provider based in Pittsfield, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649359845.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Gittzus, MD has received a total of $5,653 in payments from pharmaceutical and medical device companies, with $239.77 received in 2024. These payments were reported across 360 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($5,641).
As a Medicare-enrolled provider, Gittzus has provided services to 13,021 Medicare beneficiaries, totaling 20,391 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 116 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Pittsfield, MA
- Active Since 11/06/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1649359845
Products in Payments
- XARELTO (Drug) $548.77
- ELIQUIS (Drug) $380.37
- TRELEGY ELLIPTA (Drug) $299.44
- FARXIGA (Drug) $251.45
- TRULICITY (Drug) $233.90
- Ozempic (Drug) $221.61
- CHANTIX (Drug) $209.09
- JARDIANCE (Drug) $208.29
- XIFAXAN (Drug) $202.85
- INVOKANA (Drug) $179.74
- SYMBICORT (Drug) $168.64
- JANUVIA (Drug) $167.32
- BREO (Drug) $126.84
- Repatha (Biological) $125.00
- ENTRESTO (Drug) $121.73
- EMGALITY (Drug) $115.17
- BREZTRI (Drug) $105.82
- Cologuard Collection Kit (Device) $99.83
- Victoza (Drug) $96.73
- PREVNAR - 13 (Biological) $86.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pittsfield
David Henner, Do, DO
Internal Medicine — Payments: $97,778
Dr. Caio Teixeira Heleno, Md, MD
Internal Medicine — Payments: $6,959
Mr. Maxim Bitunov, M.d, M.D
Internal Medicine — Payments: $2,200
Cecilia Pena-Sisto, Md, MD
Internal Medicine — Payments: $1,297
Dr. Arun Bansal, Md, MD
Internal Medicine — Payments: $1,048
Richard Zuflacht, Md, MD
Internal Medicine — Payments: $905.66